Biomea Fusion, Inc. (BMEA)
NASDAQ: BMEA · Real-Time Price · USD
8.84
-0.20 (-2.21%)
At close: Nov 4, 2024, 4:00 PM
8.97
+0.13 (1.47%)
After-hours: Nov 4, 2024, 6:07 PM EST
Company Description
Biomea Fusion, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases.
Its lead product candidate is BMF-219, a covalent inhibitor of menin for treating patients with liquid and solid tumors and type 2 diabetes.
The company was incorporated in 2017 and is headquartered in Redwood City, California.
Biomea Fusion, Inc.
| Country | United States |
| Founded | 2017 |
| IPO Date | Apr 16, 2021 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 103 |
| CEO | Thomas Butler |
Contact Details
Address: 900 Middlefield Road, 4th Floor Redwood City, California 94063 United States | |
| Phone | 650 980 9099 |
| Website | biomeafusion.com |
Stock Details
| Ticker Symbol | BMEA |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $17.00 |
| CIK Code | 0001840439 |
| CUSIP Number | 09077A106 |
| ISIN Number | US09077A1060 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Thomas Andrew Butler | Co-Founder, Chairman and Chief Executive Officer |
| Ramses M. Erdtmann | Co-Founder, President, Chief Operating Officer and Director |
| Franco Valle | Chief Financial Officer and Principal Accounting Officer |
| Dr. Juan Pablo Frias M.D. | Chief Medical Officer |
| Heow Tan | Chief Technology and Quality Officer |
| Naomi Cretcher | Chief People Officer |
| Dr. Thorsten Kirschberg Ph.D. | Executive Vice President of Chemistry |
| Dr. Stephan Morris M.D. | Chief Development Officer |
| Ravi Upasani | Executive Vice President of Intellectual Property |
| Caroline Perez- Dupont | Senior Vice President of Contracts |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 31, 2024 | 8-K | Current Report |
| Oct 29, 2024 | 10-Q | Quarterly Report |
| Oct 29, 2024 | 8-K | Current Report |
| Sep 27, 2024 | 8-K | Current Report |
| Jul 31, 2024 | 10-Q | Quarterly Report |
| Jul 31, 2024 | 8-K | Current Report |
| Jul 18, 2024 | UPLOAD | Filing |
| Jul 10, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Jun 12, 2024 | 8-K | Current Report |
| Jun 12, 2024 | UPLOAD | Filing |